Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia (Q34530220)

2 August 2017

1 reference

title

Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia (English)

1 reference

2 August 2017

0 references

1 reference

1

Gerald M Reaven

1 reference

2 August 2017

1 January 2002

1 reference

Diabetes, Obesity and Metabolism

2 August 2017

1 reference

2 August 2017

4 Suppl 1

1 reference

2 August 2017

S13-8

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Management of dyslipidemia in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall--evidence that plaque cholesterol may be derived from post-prandial lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

The tangled web of coronary risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-8902.2001.00037.X

10.1046/J.1462-8902.2001.00037.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11843950